With such ambitious goals comes an immense cost. The work life balance is tipped heavily towards work. The day to day activities are demanding in both the amount of time required to execute projects, and the level focus required to ensure accuracy and quality. Not a problem for motivated career minded individuals if the work culture provided is an environment designed to cope the overwhelming stress.
Alcami, although willing to acknowledge the burden it puts on their employees, is unwilling to act in favor of supporting their personnel to meet their aggressive target for growth. Expect weekend work, and staying routinely late, however do not expect to be compensated, and do not expect to maintain a healthy lifestyle. Their bottom line, like any private business, is to ensure we are on track for the targeted growth promised to private investor(s), and if this means at the expense of an individual scientist or management, then so be it.
This is the mindset continues to be perpetuated by our Executive leadership team, trickling down to the level of site directors and project managers. This strategy lacks success in the long haul. What is currently an ever plummeting moral, will eventually turn into a revolving door for potential great talent to build their skills and depart. Leaving Alcami with a sub-par product to offer clients, and lack of innovation to be a true competitor in the contract pharma industry.
Alcami will have to endure the initial cost involved in retaining talent, but when you do Alcami will be transformed in the gold standard for how successful contract pharmaceutical organizations are operated.
